文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

《阿柏西普治疗对雷珠单抗耐药的新生血管性年龄相关性黄斑变性（nAMD）所致色素上皮脱离患者的两年结果》勘误

Corrigendum to "Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab".

作者信息

Tran Thi Ha Chau, Dumas Stéphane, Coscas Florence

机构信息

Ophthalmology Department, Lille Catholic Hospitals, Lille Catholic University, Lille, France.

Clinique de la Louvière, Lille, France.

出版信息

J Ophthalmol. 2018 Jul 8;2018:9171269. doi: 10.1155/2018/9171269. eCollection 2018.

DOI:10.1155/2018/9171269

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6079526/

Abstract

[This corrects the article DOI: 10.1155/2017/8984313.].

摘要

[本文更正了文章的数字对象标识符：10.1155/2017/8984313。]

相似文献

1

Corrigendum to "Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab".《阿柏西普治疗对雷珠单抗耐药的新生血管性年龄相关性黄斑变性（nAMD）所致色素上皮脱离患者的两年结果》勘误

J Ophthalmol. 2018 Jul 8;2018:9171269. doi: 10.1155/2018/9171269. eCollection 2018.

2

Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.在从雷珠单抗转换为阿柏西普治疗时，与新生血管性年龄相关性黄斑变性相关的色素上皮脱离的临床反应

BMC Ophthalmol. 2018 Jun 22;18(1):148. doi: 10.1186/s12886-018-0824-0.

3

Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration.阿柏西普转换为雷珠单抗治疗难治性新生血管性年龄相关性黄斑变性。

Graefes Arch Clin Exp Ophthalmol. 2020 Aug;258(8):1591-1596. doi: 10.1007/s00417-020-04730-8. Epub 2020 May 12.

4

A comparison of responses to intravitreal bevacizumab, ranibizumab, or aflibercept injections for neovascular age-related macular degeneration.玻璃体内注射贝伐单抗、雷珠单抗或阿柏西普治疗新生血管性年龄相关性黄斑变性的疗效比较。

Int Ophthalmol. 2017 Oct;37(5):1205-1214. doi: 10.1007/s10792-016-0391-4. Epub 2016 Nov 8.

5

[Comparison of Functional and Morphological Outcome after Aflibercept or Ranibizumab in Chronic Recurrent Neovascular Age-Related Macular Degeneration].阿柏西普或雷珠单抗治疗慢性复发性新生血管性年龄相关性黄斑变性后的功能和形态学结果比较

Klin Monbl Augenheilkd. 2016 Nov;233(11):1260-1265. doi: 10.1055/s-0042-101551. Epub 2016 Apr 30.

6

Indocyanine green angiography findings in patients with neovascular age-related macular degeneration refractory to ranibizumab switched to aflibercept.雷珠单抗治疗无效转而使用阿柏西普的新生血管性年龄相关性黄斑变性患者的吲哚菁绿血管造影结果

Int Ophthalmol. 2019 Nov;39(11):2441-2448. doi: 10.1007/s10792-019-01082-z. Epub 2019 Feb 14.

7

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab.阿柏西普治疗对雷珠单抗耐药的新生血管性年龄相关性黄斑变性（nAMD）所致色素上皮脱离患者的两年疗效

J Ophthalmol. 2017;2017:8984313. doi: 10.1155/2017/8984313. Epub 2017 Sep 13.

8

PIGMENT EPITHELIAL DETACHMENT RESPONSE TO AFLIBERCEPT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION REFRACTORY TO RANIBIZUMAB: Time Course and Drug Effects.阿柏西普治疗对雷珠单抗耐药的新生血管性年龄相关性黄斑变性患者色素上皮脱离的反应：时间进程和药物效应

Retina. 2016 May;36(5):881-8. doi: 10.1097/IAE.0000000000000813.

9

Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab.抗血管内皮生长因子药物治疗抵抗的新生血管性年龄相关性黄斑变性患者玻璃体内注射阿柏西普后视网膜色素上皮脱离的快速消退。

Eye (Lond). 2013 May;27(5):663-7; quiz 668. doi: 10.1038/eye.2013.31. Epub 2013 Apr 5.

10

Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment.雷珠单抗和贝伐单抗交替双周玻璃体内注射治疗伴有色素上皮脱离的难治性新生血管性年龄相关性黄斑变性

Semin Ophthalmol. 2017;32(3):309-315. doi: 10.3109/08820538.2015.1072222. Epub 2015 Sep 4.

本文引用的文献

1

Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab.阿柏西普治疗对雷珠单抗耐药的新生血管性年龄相关性黄斑变性（nAMD）所致色素上皮脱离患者的两年疗效

J Ophthalmol. 2017;2017:8984313. doi: 10.1155/2017/8984313. Epub 2017 Sep 13.